Loading...
OTCM
DSRNY
Market cap4.25bUSD
, Last price  
USD
Name

DiaSorin SpA

Chart & performance

D1W1MN
OTCM:DSRNY chart
P/E
—
P/S
—
EPS
3.15
Div yield, %
—
Shrs. gr., 5y
0.31%
Rev. gr., 5y
6.28%
Revenues
1.20b
+0.84%
179,756,000202,324,000244,612,000304,129,000404,547,000440,003,000433,763,000434,849,000443,770,000499,181,000569,312,000637,487,000669,197,000706,319,000881,305,0001,237,654,0001,361,138,0001,148,210,0001,185,000,0001,195,000,000
Net income
156m
-17.27%
22,294,00025,219,00037,459,00070,047,00090,418,00099,607,00087,396,00083,028,00084,074,000100,420,000112,383,000139,878,000158,128,000175,735,000247,871,000310,968,000240,907,000159,849,000188,105,000155,624,000
CFO
343m
-4.47%
33,976,00030,348,00047,779,00064,219,00095,791,000108,578,000110,582,000107,717,000119,847,000138,449,000165,597,000167,440,000209,879,000232,670,000304,562,000400,664,000389,341,000311,663,000358,782,000342,760,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

DiaSorin S.p.A. engages in research and development, manufacture, and distribution of immunodiagnostics and molecular diagnostics testing kits in Europe, North America, and internationally. It provides various immunodiagnostic in the areas, including infectious diseases, gastrointestinal diseases, hepatitis and retroviruses, endocrinology, metabolic disorders, tumor markers, and oncology under LIAISON XL and LIAISON XS name. The company also offers Simplexa, a congenital CMV direct kit, which detects cytomegalovirus DNA in saliva swab and urine specimens. In addition, it offers LIAISON PLEX Respiratory Flex Assay and the LIAISON PLEX Yeast Blood Culture Assay. Further, the company offers xMAP technology platform, including in vitro diagnostics. The company was founded in 1968 and is headquartered in Saluggia, Italy.

Related entities

Parent
FINDE S.P.A.
Subsidiaries (2)
DIASORIN INC.
DIASORIN ITALIA S.P.A.

Key people

Michele Denegri
Non-Executive Chairman of the Board · since 2022
Carlo Rosa
Chief Executive Officer, Executive Director, General Manager · since 2007
Giancarlo Boschetti
Non-Executive Vice Chairman of the Board · since 2022
Piergiorgio Pedron
Chief Financial Officer · since 2016
Chen Even
Executive Director, Chief Commercial Officer · since 2016
Stefano Ronchi
Senior Corporate Vice President - Human Resources · since 2007
Andre Ballester
Lead Independent Director · since 2022
Stefano Altara
Non-Executive Director · since 2014
Luca Melindo
Non-Executive Director · since 2019
Diego Pistone
Non-Executive Director · since 2022
Fiorella Altruda
Non-Executive Independent Director · since 2016
Non-Executive Independent Director · since 2007
Giovanna Parravicini
Non-Executive Independent Director · since 2022
Non-Executive Independent Director · since 2016
Roberta Somati
Non-Executive Independent Director · since 2013
Monica Tardivo
Non-Executive Independent Director · since 2016
Tullia Todros
Non-Executive Independent Director · since 2016
IPO date
Jul 19, 2007
Employees
3,278
Domiciled in
IT
Incorporated in
IT
Headquarters & legal address
VIA CRESCENTINO, SNC
SALUGGIA, VC 13040
IT

Valuation

Title
EUR in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT